Latest Avelas Biosciences Stories
Avelas Biosciences Extends Series B Financing to $7.4 Million to Support Clinical Development of Real-Time Cancer Visualization Technology
SAN DIEGO, Sept.
Avelas Biosciences Closes $6.85 Million in Series B Financing to Advance Real-Time Cancer Visualization Technology to Clinical Proof-of-Concept
New CEO and Members Appointed to Board of Directors SAN DIEGO, Jan.
Word of the Day
- Withering but not falling off, as a blossom that persists on a twig after flowering.
The word 'marcescent' comes from a Latin word meaning 'to wither'.